2021 annual financial data

Keros Therapeutics 2021 Financial results

Direct answer

Revenue was 20.1M USD.

Operating income was -56.37M USD and net income was -58.74M USD.
Operating cash flow was -62.15M USD.

Get free Keros Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
20.1M USD
Operating income
-56.37M USD
Net income
-58.74M USD
Operating cash flow
-62.15M USD